Back
Enlivex Therapeutics Vs. Fundamental Global Industry Stock Comparison
Sell
17
ENLV
Enlivex Therapeutics
Last Price:
1.06
Seasonality Move:
14.56%
Buy
60
FGF
Fundamental Global
Last Price:
31.12
Seasonality Move:
1.83%
Sell
17
Enlivex Therapeutics (ENLV)
is a Sell
Is Enlivex Therapeutics a Buy, Sell or Hold?
- The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- ENLV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Fundamental Global (FGF)
is a Buy
Is Fundamental Global a Buy, Sell or Hold?
- The current Fundamental Global [FGF] share price is $31.01. The Score for FGF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- FGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ENLV Stock Price Chart
What is Enlivex Therapeutics's stock price today?
-
The Enlivex Therapeutics share price today is $1.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ENLV is experiencing slight buying pressure.
FGF Stock Price Chart
What is Fundamental Global's stock price today?
-
The Fundamental Global share price today is $31.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGF is experiencing slight buying pressure.
ENLV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 23.24 | Sell |
Chaikin Money Flow: | 43470 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.21 - 1.53) | Sell |
Bollinger Bands (100): | (1.25 - 1.51) | Sell |
FGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.1 | Buy |
Relative Strength Index (14 RSI): | 66.15 | Buy |
Chaikin Money Flow: | 34089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0 - 20.58) | Buy |
Bollinger Bands (100): | (-3.22 - 9.84) | Buy |
ENLV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.18 | Sell |
20-day SMA: | 1.33 | Sell |
50-day SMA: | 1.43 | Sell |
200-day SMA: | 1.9 | Sell |
8-day EMA: | 1.18 | Sell |
20-day EMA: | 1.29 | Sell |
50-day EMA: | 1.37 | Sell |
200-day EMA: | 1.73 | Sell |
FGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.6 | Buy |
20-day SMA: | 12.61 | Buy |
50-day SMA: | 5.63 | Buy |
200-day SMA: | 2.3 | Buy |
8-day EMA: | 21.92 | Buy |
20-day EMA: | 15.14 | Buy |
50-day EMA: | 8.49 | Buy |
200-day EMA: | 3.34 | Buy |
Enlivex Therapeutics Earnings Growth & ENLV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.10 per share.
Fundamental Global Earnings Growth & FGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Enlivex Therapeutics Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Fundamental Global Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |